Our Resources | Association for Accessible Medicines

AAM All Access Podcast - Featuring AAM CEO Dan Leonard and Apotex President and CEO Jeff Watson

New Evidence Shows Medicare Part D Plans Continue to Fail to Get New Generics to Seniors

Jul 19, 2021 | Rachel Schwartz

AAM Releases New Report: New Generics Are Less Available in Medicare Than Commercial Plans

New Evidence Shows Medicare Part D Plans Continue to Fail to Get New Generics to Seniors

Jul 19, 2021 | Craig Burton

Seniors Are Still Missing Out on Savings in Medicare Part D

New Evidence Shows Medicare Part D Plans Continue to Fail to Get New Generics to Seniors

Jul 13, 2021 | Erica Klinger

New Evidence Shows Medicare Part D Plans Continue to Fail to Get New Generics to Seniors

AAM All Access Podcast

Jul 7, 2021 | Dan Leonard

Introducing the AAM All Access Podcast with Dan Leonard

AAM Patients - Voices of Access

Jul 6, 2021 | Erica Klinger

A New Resource Showcases Patient Stories. Are You Up Next?

Eli Hurvitz (1932–2011) | Photo by Moshe Shai

Jul 1, 2021 | Bob Billings

Thank you, Eli Hurvitz

New NAFTA - North American Generic Drugmakers Call for Rejection of New Exclusivity Period for Biologics

Jul 1, 2021 | Rachel Schwartz

AAM Statement on the Anniversary of USMCA

The Maine State House in Augusta, Maine.

Jun 30, 2021 | Rachel Schwartz

AAM Statement on Gov. Mills’ Veto of LD 1117

Aurobindo Pharma building

Jun 21, 2021 | Jewel Smith

Seamlessly Flowing: AAM Member Aurobindo Pharma

The Maine State Capitol building in Augusta

Jun 18, 2021 | Rachel Schwartz

AAM Statement on Governor Mill’s Consideration of LD 1117

United States Supreme Court in Washington DC. with Statue of the Guardian or Authority of Law.

Jun 17, 2021 | Rachel Schwartz

AAM and Biosimilars Council Statement on ACA Ruling in California v. Texas

The Maine State Capitol building in Augusta

Jun 16, 2021 | Rachel Schwartz

AAM Statement on Maine LD 1117